痰热清注射液治疗小儿病毒性肺炎的临床疗效观察  

Tanreqing Injection in the Treatment of Children's Viral Pneumonia:Observation of Clinical Efficacy

作　　者：吕秀华[1] 董传海[1] 朱应辉[1] 

机构地区：[1]山东莱芜市人民医院,莱芜市271100

出　　处：《中国药房》2007年第33期2611-2612,共2页China Pharmacy

摘　　要：目的：观察痰热清注射液对小儿病毒性肺炎的临床疗效。方法：将60例小儿病毒性肺炎患者随机分为2组，其中治疗组30例，应用痰热清注射液20mL溶于5％葡萄糖注射液250mL中静脉滴注，1次·d^-1；对照组应用利巴韦林注射液10～15mg·kg^-1溶于5％葡萄糖注射液250mL中静脉滴注，2次·d^-1。7d为1个疗程。观察2组的临床疗效和不良反应。结果：治疗组有效率为100％，对照组有效率为80％，2组之间有显著性差异（P〈0．05）；2组不良反应发生率亦具有显著性差异（P〈0．05）。结论：痰热清注射液对小儿病毒性肺炎的疗效良好，不良反应少，值得临床推广应用。OBJECTIVE： To observe the clinical efficacy of Tanreqing injection in the treatment of children＇ s viral pneu- monia. METHODS： A total of sixty children with viral pneumonia were randomly divided into 2 groups： the treatment group （n = 30） were treated with Tanreqing injection （20mL） plus Glucose （250mL） qd for 7d while the control group （n = 30） with Cibavirin （10-15mg · kg^-1） plus Glucose （250mL） bid for 7d. The primary outcome measures were clinical efficacy and ad- verse drug effects （ADRs） . RESULTS： The effective rate was 100% in the treatment group as compared with 80% in the control group, showing significant differences between the two groups（P 〈 0.05）. Furthermore, there were significant differ- ences between the two groups in ADRs （/9 〈 0.05） .CONCLUSION： Tanreqing injection is satisfactory in treating children＇ s viral pneumonia yet with less side effects, which thus deserves to be widely used in the clinic.

关 键 词：痰热清注射液 小儿病毒性肺炎 临床疗效 

分 类 号：R283.61[医药卫生—中药学] R985[医药卫生—中医学]